Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

517 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

NCT07052916

Conditions
Blood Cancer, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All protocol activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities) Commack, New York, United States
View Trial Details
Recruiting

Pilot Imaging Study of Leukemia

NCT03633955

Conditions
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Ambiguous Lineage Leukemia or Lymphoma, +16 more
Locations
  • Children's National Health System Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Recruiting

Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma

NCT07529782

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • Qilu Hospital of Shandong University Jinan, Shandong, China
  • Institute of Hematology & Blood Diseases Hospital,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

NCT06518551

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions